Sign in
4

Changes in Ownership

BIOMARIN PHARMACEUTICAL INC Filed Acc 0001567619-23-005295

President, Worldwide R&D gave up 40,799 shares (to pay taxes)

  • President, Worldwide R&D acquired 16,840 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

FUCHS HENRY J · President, Worldwide R&D

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-15 Grant or award : show line 1 in the form +16,840 228,986 D
2023-03-15 Shares withheld for taxes : show line 2 in the form −4,799 $87.74 $421,064 224,187 D
2023-03-16 Shares withheld for taxes : show line 3 in the form −36,000 $93.41 $3,362,760 188,187 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-15 Grant or award : show line 4 in the form Stock Option (Right to buy Common Stock) +38,450 38,450 D
Loading xslF345X03/doc1.xml…